RYSTIGGO 140 MG / ML SOL INJ CT FR VD INC X 2 ML (280 MG)
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1236100980014 -
GGREM
525226070029007 -
Código de barras
5413787224302
O que a fonte publica
- Detentor do registro
- UCB BIOPHARMA LTDA.
- Princípios ativos
- ROZANOLIXIZUMABE
- Embalagem
- 140 MG / ML SOL INJ CT FR VD INC X 2 ML (280 MG)
- Tipo de produto
- Biológico
- Classe terapêutica
- M5X - TODOS OS OUTROS FÁRMACOS COM AÇÃO MÚSCULO-ESQUELÉTICA
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "RYSTIGGO 140 MG / ML SOL INJ CT FR VD INC X 2 ML (280 MG)",
"holder": "UCB BIOPHARMA LTDA.",
"stripe": null,
"barcodes": [
"5413787224302"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "525226070029007",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "64.711.500/0001-14",
"priceRegime": "Regulado",
"productName": "RYSTIGGO",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "140 MG / ML SOL INJ CT FR VD INC X 2 ML (280 MG)",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "26357.94",
"icms-12": "29952.21",
"icms-17": "31756.55",
"icms-18": "32143.82",
"icms-19": "32540.67",
"icms-20": "32947.43",
"icms-21": "33364.49",
"icms-22": "33792.22",
"icms-23": "34231.08",
"icms-17.5": "31949.01",
"icms-19.5": "32742.78",
"icms-20.5": "33154.65",
"icms-22.5": "34010.26",
"icms-12-alc": "26743.06",
"icms-17-alc": "28354.05",
"icms-18-alc": "28699.84",
"icms-19-alc": "29054.15",
"icms-20-alc": "29417.33",
"icms-21-alc": "29789.72",
"icms-22-alc": "30171.62",
"icms-23-alc": "30563.45",
"withoutTaxes": "23533.87",
"icms-17.5-alc": "28525.91",
"icms-19.5-alc": "29234.62",
"icms-20.5-alc": "29602.34",
"icms-22.5-alc": "30366.27"
},
"pisCofinsList": "Negativa",
"substanceText": "ROZANOLIXIZUMABE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "35358.24",
"icms-12": "40179.82",
"icms-17": "42600.28",
"icms-18": "43119.79",
"icms-19": "43652.15",
"icms-20": "44197.80",
"icms-21": "44757.28",
"icms-22": "45331.06",
"icms-23": "45919.78",
"icms-17.5": "42858.46",
"icms-19.5": "43923.27",
"icms-20.5": "44475.78",
"icms-22.5": "45623.55",
"icms-12-alc": "36970.71",
"icms-17-alc": "39197.81",
"icms-18-alc": "39675.85",
"icms-19-alc": "40165.66",
"icms-20-alc": "40667.73",
"icms-21-alc": "41182.54",
"icms-22-alc": "41710.49",
"icms-23-alc": "42252.18",
"withoutTaxes": "32534.20",
"icms-17.5-alc": "39435.40",
"icms-19.5-alc": "40415.15",
"icms-20.5-alc": "40923.50",
"icms-22.5-alc": "41979.59"
},
"invalidBarcodes": [],
"activeSubstances": [
"ROZANOLIXIZUMABE"
],
"therapeuticClass": "M5X - TODOS OS OUTROS FÁRMACOS COM AÇÃO MÚSCULO-ESQUELÉTICA",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": "(AR)",
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1236100980014",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "M5X",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:525226070029007"